These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 10693152
1. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Ströhle A, Holsboer F, Rupprecht R. Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152 [Abstract] [Full Text] [Related]
2. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K. Depress Anxiety; 2006 Mar; 23(3):139-44. PubMed ID: 16470820 [Abstract] [Full Text] [Related]
3. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms? Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M. Psychoneuroendocrinology; 2017 Feb; 76():14-18. PubMed ID: 27871026 [Abstract] [Full Text] [Related]
4. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone. Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K. World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662 [Abstract] [Full Text] [Related]
5. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R. Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707 [Abstract] [Full Text] [Related]
6. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E. Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707 [Abstract] [Full Text] [Related]
7. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Wiedemann K, Jahn H, Yassouridis A, Kellner M. Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098 [Abstract] [Full Text] [Related]
8. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4). Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F. Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979 [Abstract] [Full Text] [Related]
9. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R. Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826 [Abstract] [Full Text] [Related]
10. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder. Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR. Psychoneuroendocrinology; 2012 Aug 15; 37(8):1199-208. PubMed ID: 22277728 [Abstract] [Full Text] [Related]
11. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R. Neuropsychopharmacology; 2001 Nov 15; 25(5):699-703. PubMed ID: 11682253 [Abstract] [Full Text] [Related]
12. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4. Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C. J Psychiatr Res; 2009 Jan 15; 43(4):393-400. PubMed ID: 18534623 [Abstract] [Full Text] [Related]
13. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Kellner M, Yassouridis A, Jahn H, Wiedemann K. Psychopharmacology (Berl); 1997 Sep 15; 133(1):55-61. PubMed ID: 9335081 [Abstract] [Full Text] [Related]
14. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks. Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K. J Psychiatr Res; 2010 Dec 15; 44(16):1148-53. PubMed ID: 20451215 [Abstract] [Full Text] [Related]
15. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Abelson JL, Khan S, Liberzon I, Young EA. Depress Anxiety; 2007 Dec 15; 24(1):66-76. PubMed ID: 16845643 [Abstract] [Full Text] [Related]
16. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects. Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A. J Psychopharmacol; 2009 Jun 15; 23(4):460-4. PubMed ID: 18562429 [Abstract] [Full Text] [Related]
17. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R. J Psychopharmacol; 2011 Jan 15; 25(1):52-9. PubMed ID: 20498136 [Abstract] [Full Text] [Related]
18. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J. Depress Anxiety; 1998 Jan 15; 8(1):1-7. PubMed ID: 9750972 [Abstract] [Full Text] [Related]
19. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic. Ruland T, Domschke K, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P. Eur Neuropsychopharmacol; 2015 Oct 15; 25(10):1677-82. PubMed ID: 26235955 [Abstract] [Full Text] [Related]
20. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B. Neuropsychopharmacology; 2013 Aug 15; 38(9):1648-54. PubMed ID: 23463151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]